By Brian Amaral ( September 26, 2017, 7:36 PM EDT) -- Sanofi-Aventis urged a Massachusetts magistrate judge Tuesday to dismiss an antitrust suit over its Lantus diabetes treatments, arguing that it reasonably listed its products in the so-called Orange Book and that its patent litigation against Eli Lilly was not a sham....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.